ketorolac (SteadyMed Therapeutics)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Nameketorolac (SteadyMed Therapeutics)
Drug Alias NameNSAID therapeutic (SteadyMed Therapeutics)ketorolacSMT-201
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclooxygenases inhibitorsThioredoxin reductase 1 inhibitors
TargetsCyclooxygenasesThioredoxin reductase 1
Therapy Area/IndicationsPain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSteadymed Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSteadymed Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsPain

Other Information

ATC CodeN/A
Related LinksN/A